Sexual Dysfunction

“I would classify hidden burdens as things which we don't appreciate on the surface, or that aren't obvious that are associated with erectile dysfunction,” says John J. Mulcahy, MD, PhD.

“Collagenase [clostridium histolyticum (Xiaflex)] is a really important part of our treatment armamentarium,” says Matthew J. Ziegelmann, MD.

“[Collagenase clostridium histolyticum (Xiaflex)] is an incredibly important part of the treatment armamentarium for Peyronie's disease in the US,” says Matthew J. Ziegelmann, MD.

“I think the most notable finding is that we did see continued benefit from each injection series,” says Matthew J. Ziegelmann, MD.

“I am interested in looking at postpartum issues for sexual function,” says Rachel Pope, MD, MPH.

“For a lot of women with lichen sclerosis, they actually go for years without being diagnosed,” says Rachel Pope, MD, MPH.

“I would have to say the most exciting part of the whole conference was how many medical students and trainees were there,” says Rachel Pope, MD, MPH.

“I would just burn it into everyone's brain that pain with intercourse is also going to be associated with genitourinary syndrome of menopause,” says Rachel Pope, MD, MPH.

“There's a huge potential role for urologists out there for female sexual health,” says Rachel Pope, MD, MPH.

“There are just a lot of barriers, unfortunately, to speaking freely about women's sexual health,” says Rachel Pope, MD, MPH.

The spray is a liquid suspension of sildenafil citrate administered orally via a spray pump.

In this interview, Ira Sharlip, MD, explains the potential dangers these products pose and what urologists can do to help protect their patients.

“What we found is that the majority of these companies…offered our ‘secret shopper’ testosterone therapy,” says Joshua A. Halpern, MD, MS.

This clinical consensus statement on vaginal energy-based devices (EBDs) reflects an update by content experts from the American Urogynecologic Society’s EBD writing group.

“We're trying to see if combining shockwave therapy along with PRP will make an additive impact on the improvement in erectile function in men with erectile dysfunction,” says Ranjith Ramasamy, MD.

“I think a clinical trial like this that is funded by the NIH and taxpayer dollars will hopefully provide an unbiased answer of whether it works and who it works in,” says Ranjith Ramasamy, MD.

Treatment of azoospermia after exogenous testosterone use may require aggressive medical therapy, according to Kelli Gross, MD.

Joshua A. Broghammer, MD, discusses the development and use of intracavernosal injections for the treatment of patients with erectile dysfunction.

Joshua A. Broghammer, MD, discusses the use of penile implants in the field of urology, detailing both the semi-rigid and inflatable penile prostheses.

“Community urologists need to interact more intimately with academic urologists so all of us have a voice in this direct-to-consumer conversation," says 1 urologist.

Among the topics touched on in the discussion are lifestyle considerations, medical therapy, and surgical options.

Many of the medications used in the treatment of ED have interactions with other medications, so it is crucial to carefully examine patient profiles to optimize therapy and ensure safety.

“These are men who are suffering in silence. Many of them are too embarrassed to ever discuss their sexual health problems,” says Mohit Khera, MD, MBA, MPH.

"As clinicians, we must better understand how race plays a role in fertility therapy," writes Mary K. Samplaski, MD.

“For the first time, we have 20-year follow-up data after the penile prosthesis,” says Mohit Khera, MD, MBA, MPH.

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Denise Asafu-Adjei, MD, MPH, discusses the development of microsurgical testicular sperm extraction.

"Micro TESE is associated with higher sperm retrieval rates compared with conventional testicular sperm extraction, so this approach has really become the gold standard for sperm extraction in patients with non-obstructive azoospermia," says Denise Asafu-Adjei, MD, MPH.

Urologists made up only 25% of shock wave therapy providers and 13% of the providers were not physicians.

"Now, men have the option to seek out something minimally invasive before surgical options are breached," says Denise Asafu-Adjei, MD, MPH.

"Peyronie's disease has really seen a wide range of intralesional options through the years," says Denise Asafu-Adjei, MD, MPH.